Showing results (2021-2030 of 2,148) with videos related to

Sort By:
Pageof 215
Neurosurgery|February 16, 2026
Treatment Algorithms From the Brain Trauma Foundation Guidelines for the Management of Penetrating Traumatic Brain Injury, Second EditionRandy S Bell, Angela Lumba-Brown, David W Wright, et al.
Injury|September 9, 2022
Does treatment delay for blunt cerebrovascular injury affect stroke rate?: An EAST multicenter studyRachel D Appelbaum, Emily Esposito, M Chance Spaulding, et al.
Leukemia & Lymphoma|September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplantJan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Neurotrauma Reports|August 3, 2022
Rationale and Methods for Updated Guidelines for the Management of Penetrating Traumatic Brain InjuryGregory W J Hawryluk, Shelley Selph, Angela Lumba-Brown, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Blood|October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 studyEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
The Journal of Trauma and Acute Care Surgery|November 5, 2021
Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter studyEmily C Esposito, Joseph A Kufera, Timothy W Wolff, et al.
BMJ Open|March 25, 2021
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patientsRobert V O'Toole, Deborah M Stein, Katherine P Frey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.
Cancer Discovery|October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase InhibitionJames J Harding, Maeve A Lowery, Alan H Shih, et al.
Pageof 215